Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases

被引:6
|
作者
Draskovic, Tina [1 ]
Hauptman, Nina [1 ]
机构
[1] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia
关键词
TUMOR-SUPPRESSOR; UNKNOWN PRIMARY; CANCER GENOME; ARRAY; PROFILES; GENES; VALIDATION; LANDSCAPES; EXPRESSION; CARCINOMA;
D O I
10.1038/s41598-024-53754-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Differentiation between adenocarcinomas is sometimes challenging. The promising avenue for discovering new biomarkers lies in bioinformatics using DNA methylation analysis. Utilizing a 2853-sample identification dataset and a 782-sample independent verification dataset, we have identified diagnostic DNA methylation biomarkers that are hypermethylated in cancer and differentiate between breast invasive carcinoma, cholangiocarcinoma, colorectal cancer, hepatocellular carcinoma, lung adenocarcinoma, pancreatic adenocarcinoma and stomach adenocarcinoma. The best panels for cancer type exhibit sensitivity of 77.8-95.9%, a specificity of 92.7-97.5% for tumors, a specificity of 91.5-97.7% for tumors and normal tissues and a diagnostic accuracy of 85.3-96.4%. We have shown that the results can be extended from the primary cancers to their liver metastases, as the best panels diagnose and differentiate between pancreatic adenocarcinoma liver metastases and breast invasive carcinoma liver metastases with a sensitivity and specificity of 83.3-100% and a diagnostic accuracy of 86.8-91.9%. Moreover, the panels could detect hypermethylation of selected regions in the cell-free DNA of patients with liver metastases. At the same time, these were unmethylated in the cell-free DNA of healthy donors, confirming their applicability for liquid biopsies.
引用
收藏
页数:25
相关论文
共 20 条
  • [1] Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases
    Tina Draškovič
    Nina Hauptman
    Scientific Reports, 14
  • [2] DNA Methylation Panels for the Differentiation of Lung and Gastric Adenocarcinomas from Other Common Primary Adenocarcinomas
    Draskovic, Tina
    Omahen, Lara
    Jerse, Maja
    Zidar, Nina
    Hauptman, Nina
    CANCERS, 2024, 16 (23)
  • [3] DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases
    Draskovic, Tina
    Rankovic, Branislava
    Zidar, Nina
    Hauptman, Nina
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [4] Improved Noninvasive Bladder Cancer Diagnosis using Urine Sediments and Novel DNA Methylation Biomarker Panels
    Wang, Kaichen
    Tian, Yudan
    Xu, Hongmei
    CLINICAL LABORATORY, 2016, 62 (03) : 327 - 336
  • [5] A novel approach toward optimal workflow selection for DNA methylation biomarker discovery
    Nazer, Naghme
    Sepehri, Mohammad Hossein
    Mohammadzade, Hoda
    Mehrmohamadi, Mahya
    BMC BIOINFORMATICS, 2024, 25 (01)
  • [6] A novel approach toward optimal workflow selection for DNA methylation biomarker discovery
    Naghme Nazer
    Mohammad Hossein Sepehri
    Hoda Mohammadzade
    Mahya Mehrmohamadi
    BMC Bioinformatics, 25
  • [7] Identification and validation of new DNA methylation panels for the differentiation between hepatocellular carcinoma and cholangiocarcinoma
    Draskovic, Tina
    Hauptman, Nina
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1272 - 1272
  • [8] Discovery and Validation of a Novel DNA Methylation Biomarker for Colorectal Cancer With Application to Blood Testing
    Pedersen, Susanne K.
    Molloy, Peter L.
    Baker, Rohan
    McEvoy, Aidan
    Thomas, Melissa L.
    Murray, David H.
    Dunne, Rob
    Lockett, Trevor
    Mitchell, Susan M.
    Ho, Thu
    Ross, Jason P.
    Brown, Glenn
    Duesing, Konsta
    Saunders, Neil F.
    Buckley, Michael
    Drew, Horace R.
    Young, Graeme P.
    LaPointe, Lawrence C.
    GASTROENTEROLOGY, 2012, 142 (05) : S33 - S33
  • [9] From discovery to the clinic: the novel DNA methylation biomarker mSEPT9 for the detection of colorectal cancer in blood
    Payne, Shannon R.
    EPIGENOMICS, 2010, 2 (04) : 575 - 585
  • [10] Distinctive methylation patterns on circulating DNA as a novel non-invasive biomarker of graft pathology in liver transplant recipients
    Baciu, C.
    Pasini, E.
    De Carvalho, D.
    Bhat, M.
    TRANSPLANTATION, 2022, 106 (8S) : 173 - 174